CIVALLERO, Monica
 Distribuzione geografica
Continente #
NA - Nord America 4.217
AS - Asia 1.739
EU - Europa 1.533
SA - Sud America 259
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 4
Totale 7.865
Nazione #
US - Stati Uniti d'America 4.141
SG - Singapore 524
CN - Cina 464
GB - Regno Unito 435
IT - Italia 361
VN - Vietnam 206
HK - Hong Kong 204
BR - Brasile 183
SE - Svezia 154
DE - Germania 130
RU - Federazione Russa 86
FI - Finlandia 82
BD - Bangladesh 81
FR - Francia 65
UA - Ucraina 65
TR - Turchia 51
CA - Canada 39
KR - Corea 36
IN - India 32
ID - Indonesia 28
IE - Irlanda 28
BG - Bulgaria 24
AR - Argentina 22
JP - Giappone 21
MA - Marocco 19
BE - Belgio 18
NL - Olanda 18
MX - Messico 17
IQ - Iraq 16
ZA - Sudafrica 16
EC - Ecuador 14
MY - Malesia 12
CL - Cile 10
PE - Perù 9
PK - Pakistan 9
AT - Austria 8
EG - Egitto 7
LB - Libano 7
LT - Lituania 7
PL - Polonia 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
ES - Italia 6
JO - Giordania 5
ET - Etiopia 4
JM - Giamaica 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CO - Colombia 3
IR - Iran 3
KE - Kenya 3
NI - Nicaragua 3
PR - Porto Rico 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
Totale 7.803
Città #
Ashburn 560
Fairfield 375
Santa Clara 360
Singapore 331
Southend 304
Chandler 259
Woodbridge 236
Hong Kong 201
San Jose 197
Houston 164
Ann Arbor 130
Seattle 123
Cambridge 117
Nyköping 109
Wilmington 104
Council Bluffs 102
Beijing 89
Jacksonville 84
Hefei 82
London 80
Dearborn 78
New York 65
Los Angeles 62
Helsinki 61
Modena 59
Ho Chi Minh City 58
The Dalles 58
Hanoi 54
Chicago 42
Milan 41
San Diego 40
Seoul 36
Dallas 31
Frankfurt am Main 31
Dublin 28
Izmir 27
Princeton 25
Moscow 24
Sofia 24
Shanghai 23
Fremont 22
Jakarta 22
Lauterbourg 22
Munich 22
Eugene 19
São Paulo 19
Brussels 18
Columbus 18
Salt Lake City 18
Buffalo 17
Casablanca 16
Cologno Monzese 16
Boardman 13
Atlanta 12
Naples 12
Norwalk 12
Tokyo 12
Des Moines 10
Orem 10
Phoenix 10
Pisa 10
Johannesburg 9
Miami 9
Montreal 9
San Francisco 9
San Giuliano Milanese 9
Toronto 9
Bremen 8
Falls Church 8
Lviv 8
North Bergen 8
Rome 8
Amsterdam 7
Brusaporto 7
Chongqing 7
Da Nang 7
Haiphong 7
Lima 7
Nuremberg 7
Parma 7
Redondo Beach 7
Bologna 6
Boston 6
Brooklyn 6
Changsha 6
Contagem 6
Dong Ket 6
Guangzhou 6
Philadelphia 6
Quito 6
Redwood City 6
Baghdad 5
Brasília 5
Campinas 5
Caracas 5
Kuala Lumpur 5
Lappeenranta 5
Latina 5
Mexico City 5
Ottawa 5
Totale 5.466
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 396
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 381
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 378
Activity of BKM120 and BEZ235 against lymphoma cells 377
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 357
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 355
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 321
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 297
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 295
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 295
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 292
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 291
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 286
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 286
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 276
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 273
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 263
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 258
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 256
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 249
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 243
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 240
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 215
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 210
COVID-related disruption in mammographic screening: a year later. 182
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 169
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 158
The Value and relevance of T-cell lymphoma registries 153
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 66
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study. 29
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center. 18
Totale 7.865
Categoria #
all - tutte 30.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022490 0 0 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20262.581 176 84 165 227 323 188 343 145 274 251 261 144
2026/2027351 179 165 7 0 0 0 0 0 0 0 0 0
Totale 7.865